Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ · Manufacturing · Pharmaceutical preparations
RCKT price, last 12 months
Key stats
- Previous close
- $2.11
- Open
- $2.14
- Day range
- $2.03 – $2.27
- 52-week range
- $1.90 – $5.45
- Volume
- 2.6M
- Avg volume (20 days)
- 1.7M
- Market cap
- $256.8M
Performance
Technicals and fundamentals
About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $256.8M